top of page
AI pixabay huge.jpg

Biopharma in Digital Health

I. Integration of Digital Health by pharmaceuticals is beginning to gain focus, with the average maturity of new pharmaceutical portfolio ventures in 2022 exceeding the average total portfolio maturity


II. Digital Health solutions for Research and Clinical Trials dominate pharmaceutical portfolios, with 25% of the smallest portfolios (1 to 2 ventures) including ventures in the Research Solutions cluster and 14% including ventures in the Clinical Trials cluster


III. Rankings





Comentarios


bottom of page